At last, VISTA mRNA expression levels appeared to be the highest in all glioma cases (low and high grade) when compared to those of other critical immune checkpoints, Tim-3, PD-1, CTLA-4, LAG-3 and TIGIT (p < 0.0001) (Fig. 4b). This evidence concerns the gene PDCD1 and central nervous system cancer.